House Democrats ramp up probe of FDA approval of Alzheimer’s drug – NewsBreak

September 7, 2021

Democratic leaders of two House committees are stepping up a probe of the Food and Drug Administration’s (FDA) controversial approval of the Alzheimer’s drug Aduhelm, pressing the agency for information on “anomalies” in the approval process. In a letter to FDA sent Wednesday, House Energy and Commerce Committee Chair Frank Pallone, Jr. (N.J.) and Oversight and Reform Chair Carolyn Maloney (N.Y.) said “significant questions” remain even after FDA staff briefed their panels.

Read the source article at News Break
2021-09-02 21:33:00

Share This Story!